Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson’s Disease?
Darren M. O’Hara, Grishma Pawar, Suneil K. Kalia, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Solving neurodegeneration: common mechanisms and strategies for new treatments
Lauren K. Wareham, Shane A. Liddelow, Sally Temple, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 196
Microglia Phenotypes in Aging and Neurodegenerative Diseases
Menbere Wendimu, Shelley B. Hooks
Cells (2022) Vol. 11, Iss. 13, pp. 2091-2091
Open Access | Times Cited: 188
The cell biology of Parkinson’s disease
Nikhil Panicker, Preston Ge, Valina L. Dawson, et al.
The Journal of Cell Biology (2021) Vol. 220, Iss. 4
Open Access | Times Cited: 111
Antioxidant and Neuroprotective Effects of Caffeine against Alzheimer’s and Parkinson’s Disease: Insight into the Role of Nrf-2 and A2AR Signaling
Muhammad Ikram, Tae Ju Park, Tahir Ali, et al.
Antioxidants (2020) Vol. 9, Iss. 9, pp. 902-902
Open Access | Times Cited: 113
Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson's disease
Kai Zhang, Shiou Zhu, Jiamei Li, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 10, pp. 3015-3034
Open Access | Times Cited: 93
The Mitochondrial Permeability Transition: Nexus of Aging, Disease and Longevity
Hagai Rottenberg, Jan B. Hoek
Cells (2021) Vol. 10, Iss. 1, pp. 79-79
Open Access | Times Cited: 65
The spectrum of neurodevelopmental, neuromuscular and neurodegenerative disorders due to defective autophagy
Celine Deneubourg, Mauricio Ramm, Luke J. Smith, et al.
Autophagy (2021) Vol. 18, Iss. 3, pp. 496-517
Open Access | Times Cited: 62
Small-molecule LRRK2 inhibitors for PD therapy: Current achievements and future perspectives
Jiarui Hu, Dan Zhang, Keyue Tian, et al.
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115475-115475
Closed Access | Times Cited: 29
Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson’s Disease
Kamil Saramowicz, Natalia Siwecka, Grzegorz Galita, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 360-360
Open Access | Times Cited: 24
The Potentiality of Natural Products and Herbal Medicine as Novel Medications for Parkinson’s Disease: A Promising Therapeutic Approach
Y. So, Jae-Ung Lee, Ga-Seung Yang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1071-1071
Open Access | Times Cited: 11
LRRK2 kinase activity regulates GCase level and enzymatic activity differently depending on cell type in Parkinson’s disease
Maria Kedariti, Emanuele Frattini, Pascale Baden, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 29
Advancements in Genetic and Biochemical Insights: Unraveling the Etiopathogenesis of Neurodegeneration in Parkinson’s Disease
Yashumati Ratan, Aishwarya Rajput, Ashutosh Pareek, et al.
Biomolecules (2024) Vol. 14, Iss. 1, pp. 73-73
Open Access | Times Cited: 8
The Cell Biology of LRRK2 in Parkinson's Disease
Ahsan Usmani, Farbod Shavarebi, Annie Hiniker
Molecular and Cellular Biology (2021) Vol. 41, Iss. 5
Open Access | Times Cited: 34
The role of the endolysosomal pathway in α-synuclein pathogenesis in Parkinson’s disease
Jessica Smith, George D. Mellick, Alex M. Sykes
Frontiers in Cellular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 16
Genetic heterogeneity on sleep disorders in Parkinson’s disease: a systematic review and meta-analysis
Jingxuan Huang, Yangfan Cheng, Chunyu Li, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 20
The Nigral Coup in Parkinson’s Disease by α-Synuclein and Its Associated Rebels
Jeswinder Sian‐Hülsmann, Peter Riederer
Cells (2021) Vol. 10, Iss. 3, pp. 598-598
Open Access | Times Cited: 27
Bioengineered models of Parkinson’s disease using patient-derived dopaminergic neurons exhibit distinct biological profiles in a 3D microenvironment
Nicholas J. Fiore, Yosif Ganat, Kapil Devkota, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 2
Open Access | Times Cited: 18
Genetic mutations in kinases: a comprehensive review on marketed inhibitors and unexplored targets in Parkinson's disease
Amir Raza, Jeevika Raina, Sanjeev Kumar Sahu, et al.
Neurological Sciences (2025)
Closed Access
α-Synuclein Degradation in Brain Pericytes Is Mediated via Akt, ERK, and p38 MAPK Signaling Pathways
Miki Yokoya, Fuyuko Takata, Takuro Iwao, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1615-1615
Open Access
Therapeutic potential and limitation of condensed and hydrolyzed tannins in Parkinson's disease
Ran Zhao, Nan Jia, Shuyang Wu, et al.
International Journal of Biological Macromolecules (2025), pp. 141814-141814
Closed Access
Leucine-rich repeat kinase 2 promotes disintegration of retinal pigment epithelial cell: Implication in the pathogenesis of dry age-related macular degeneration
Yuka Suimon, M Nishimura, Miyuki Murata, et al.
American Journal Of Pathology (2025)
Open Access
Co-occurrence of parkinson disease and multiple sclerosis - a critical note
K. A. Jellinger
Journal of Neural Transmission (2025)
Closed Access
Therapeutic targeting of autosomal Parkinson’s disease by modulation of Leucine-Rich Repeat Kinase 2 (LRRK2) protein
Zeeshan Hyderi, M Shirin Farhana, T.P. Singh, et al.
Brain Research (2025), pp. 149674-149674
Closed Access
Immunological Features of LRRK2 Function and Its Role in the Gut-Brain Axis Governing Parkinson’s Disease
Inga Peter, Warren Strober
Journal of Parkinson s Disease (2023) Vol. 13, Iss. 3, pp. 279-296
Open Access | Times Cited: 9
Concomitant protein pathogenesis in Parkinson’s disease and perspective mechanisms
Yuliang Han, Zhuohao He
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top